Skip to main content
. 2005 May;49(5):1823–1829. doi: 10.1128/AAC.49.5.1823-1829.2005

TABLE 4.

Class 1 and class 2 integrons found among E. coli isolates from clinical specimens (ESBL and non-ESBL) and from healthy volunteers

RFLP type Length of variable region (bp) Gene cassettes and order Resistance phenotypea No. of isolates C-ESBL (n = 52)
C-nESBL (n = 43) V-nESBL (n = 38) Isolation date
TEM SHV CT-X-M-9/14 CTX-M-10
Class 1 integrons
    I1 1,000 aadA1 Sm Sp 15 0 4 3 0 6 2 1988-2001
    II1 1,500 dhfrA1-aadA1 Tmp Sm Sp 12 1 2 2 0 5 2 1997-2001
    III1 1,800 dhfrA12-orfF-aadA2 Tmp Sm Sp 1 1 0 0 0 0 0 1997
    IV1 1,500 dhfrA16-aadA2 Tp Sm Sp 13 0 0 13 0 0 0 1996-2000
    V1 950 aadA2 Sm Sp 1 0 0 1 0 0 0 1998
    VI1 1,500 dhfrA17-aadA5 Tp Sm Spc 5 1 0 0 0 3 1 1997-2001
    VII1 800 aac(6)-Ib" Km Ak Tb Nt Gm 2 1 0 0 0 0 1 2000-2001
Class 2 integrons
    I2 1,600 sat-aadA1-orfX Str Sm Sp 2 0 0 0 0 0 2 2001
    II2 1,900 dhfrA1-sat-aadA1-orfX Tp Str Sm Sp 15 3 0 3 0 5 4 1991-2001
    III2 2,300 orf-sat-aadA1-orfX Str Sm Sp 1 0 1 0 0 0 0 2000
a

Sm, streptomycin; Sp, spectinomycin; Tp, trimethoprim; Km, kanamycin; Ak, amikacin; Tb, tobramycin; Nt, netilmicin; Gm, gentamicin; Str, streptotricin.